This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Heart Disease Heart Failure Outcomes 
Circulation
JANUARY 27, 2025
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Heart BMJ
FEBRUARY 12, 2025
Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Dates of first AA and HF presentations were documented, and outcomes of RFA, including acute and long-term success, were assessed.
Frontiers in Cardiovascular Medicine
JANUARY 28, 2025
Care for survivors after an acute attack of COVID-19 should include paying close attention to cardiovascular health and disease.Systematic Review RegistrationPROSPERO [CRD42022353965].
95 
Science Daily - Heart Disease
MAY 14, 2024
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care.
133 
Frontiers in Cardiovascular Medicine
JANUARY 22, 2025
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heart failure. The primary outcome was survival at the follow-up evaluation.
Open Heart
MAY 23, 2024
Background and aims Pre-eclampsia complicates 3–5% of pregnancies worldwide and is associated with adverse outcomes for the mother and the offspring. Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes.
DAIC
FEBRUARY 21, 2024
Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. She is only the third patient in the U.S. to receive the device.
105 
European Journal of Heart Failure
DECEMBER 11, 2024
Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
Science Daily - Heart Disease
AUGUST 22, 2024
The researchers looked at data from 4,286 people -- out of a total of 17,605 from the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial who were randomly assigned either semaglutide or a placebo -- who were followed up over an average of more than three years.
121 
DAIC
DECEMBER 19, 2023
These “off the shelf” mesenchymal stem cells (MSC) utilized for the study treatment are immunomodulatory with potential for impact on inflammatory processes in heart failure and have been shown to release multiple critical angiogenic factors that can enhance microvascular function and capillary networks in ischemic tissues.
105 
European Journal of Heart Failure
NOVEMBER 26, 2024
Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF). BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.34), ischaemic heart disease (HR 1.20, 95% CI 1.09–1.31),
Circulation
MAY 29, 2024
With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood.
DAIC
JULY 12, 2024
This is paving the way for faster, non-invasive and more accurate diagnosis of heart failure and other cardiac conditions. Garg said: “The AI model precisely determined the size and function of the heart's chambers and demonstrated outcomes comparable to those acquired by doctors manually but much quicker.
122 
DAIC
JUNE 18, 2024
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. to 61% of the U.S. population.
105 
Circulation
JANUARY 24, 2024
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
DAIC
JULY 11, 2024
mtaschetta-millane Thu, 07/11/2024 - 10:53 July 11, 2024 — Heart Test Laboratories, Inc. Heart failure (HF) is a growing worldwide public health issue affecting 64 million people annually 1 and is associated with high mortality, lower quality of life and reduced physical capacity while placing substantial costs on the healthcare system.
Circulation
NOVEMBER 11, 2024
Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes.
DAIC
JANUARY 29, 2024
years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 The primary focus was on 5-year survival rates.
111 
Conquering CHD
JANUARY 17, 2025
Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. After struggling with heart failure for the first months of his life, doctors told his parents that Zeke would need a heart transplant immediately.
DAIC
MAY 17, 2024
Implicity was the first private company authorized to access the Health Data Hub , one of the largest databases of patients with heart disease in the world. Heart failure remains a significant healthcare challenge, contributing to approximately one million hospitalizations each year.
Stroke: Vascular and Interventional Neurology
OCTOBER 24, 2024
BackgroundAlthough many studies have examined the influence of individual preexisting heart conditions on stroke outcomes, the combined effects of these conditions remain understudied.MethodsThe data supporting this study's findings are available from the corresponding author upon reasonable request.
Cardiovascular Diabetology
MAY 8, 2024
The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM.
59 
Science Daily - Heart Disease
APRIL 22, 2024
This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. These results pave the way for integration into wearable technologies, allowing early interventions and better patient outcomes. It gives early warnings on average 30 minutes before onset, with an accuracy of around 80%.
119 
Global Cardiac Surgery
AUGUST 19, 2018
On May, 25th 2018 (coinciding with Global Surgery Day), the World Health Organization (WHO) and its Member States unanimously accepted the Global Resolution on Rheumatic Fever and Rheumatic Heart Disease (RHD) at the World Health Assembly in Geneva, Switzerland. Although largely preventable, 33.4
Journal of the American Heart Association
NOVEMBER 29, 2023
BackgroundLittle is known about outcomes following heart failure (HF) hospitalization among adults with congenital heart disease (CHD) in the United States.
Open Heart
MAY 31, 2022
Aims This study aims to (1) define the characteristics of patients with a first admission for heart failure (HF), stratified by type (reduced (HFrEF) vs preserved (HFpEF) ejection fraction) in a regional Australian setting; (2) compare the outcomes in terms of mortality and rehospitalisation and (3) assess adherence to the treatment guidelines.
DAIC
APRIL 9, 2024
Decline in exercise ability is a hallmark of progression to overt heart failure. These results also speak to the importance of continuing to focus on earlier recognition of heart failure risk in patients with diabetes and on initiating treatment before the condition has progressed to overt heart failure.”
Open Heart
AUGUST 10, 2023
Background Atrial fibrillation (AF) is common in individuals with heart failure (HF). The change in incremental shuttle walking test, Heart Disease Quality of Life questionnaire, Hospital Anxiety and Depression Scores were compared between groups pre-CR and post-CR.
Circulation: Cardiovascular Interventions
NOVEMBER 9, 2023
Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).
Heart BMJ
DECEMBER 20, 2023
Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases of midgut neuroendocrine tumours (NETs), we aimed to describe the perioperative management and short-term outcomes of CHD.
Open Heart
JUNE 1, 2022
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE).
All About Cardiovascular System and Disorders
APRIL 26, 2024
The Sleep Heart Health Study found that obstructive sleep apnea with excessive daytime sleepiness triples the chance of heart failure and doubles the risk of a heart disease event. The same subtype was associated with increased risk of new occurrence of heart disease. Am J Respir Crit Care Med.
DAIC
JANUARY 14, 2025
13, A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk of stroke, atrial fibrillation and heart failure, while current pipe use was associated with increased risk of heart failure. tim.hodson Tue, 01/14/2025 - 10:11 Jan.
Open Heart
DECEMBER 15, 2022
The aim of this study was to investigate the association of preoperative imaging and haemodynamic data derived from echocardiography (ECHO), cardiac magnetic resonance (CMR) and right heart catheterisation (RHC) with postoperative outcomes following TVS. The primary outcome occurred in 16 patients (27%) with a 1-year mortality of 7%.
52 
European Journal of Heart Failure
FEBRUARY 19, 2024
Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Abstract Aims Tricuspid regurgitation (TR) is commonly observed in patients with severe left-sided valvular heart disease (VHD).
40 HeartRhythm
SEPTEMBER 4, 2024
Recent data suggest that sodium-glucose contransporter-2 inhibitors (SGLT2i) may mitigate development of cardiac arrythmias in patients with heart failure with preserved ejection fraction and patients with ischemic heart disease [1].
Journal of Cardiovascular Electrophysiology
DECEMBER 8, 2023
Abstract Introduction Cardiac resynchronization therapy (CRT) is a standard treatment for patients with heart failure with reduced ejection fraction. However, there is still a gap of evidence in congenital heart disease (CHD) patients regarding resynchronization therapy.
Journal of the American Heart Association
JANUARY 19, 2024
BackgroundSystemic chronic inflammation plays a role in the pathophysiology of both heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction‐associated fatty liver disease. The study outcome was time to the first hospitalization for HF. In 10 019 middle‐aged individuals (mean age, 63.3±10.6
DAIC
JULY 9, 2024
Getty Images mtaschetta-millane Tue, 07/09/2024 - 07:23 July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet nearly half of U.S. The ACC aims to achieve a culture of equitable cardiovascular care and heart health for all.
103 
DAIC
FEBRUARY 2, 2024
The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team. Edwards expects to present the full cohort of 392 TRISCEND II pivotal trial patients at TCT 2024.
100 
Medical Xpress - Cardiology
MARCH 13, 2025
Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors.
40 
DAIC
AUGUST 27, 2024
We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. This milestone makes AISAP the first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heart diseases using POCUS.
98 
DAIC
FEBRUARY 29, 2024
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
103 
DAIC
JUNE 4, 2024
fold higher risk for major adverse cardiac events (MACE) Caristo's AI-Risk model, CaRi-Heart Risk Score, outperformed other scores in routine clinical use for prediction of cardiac mortality, and when presented to clinicians, resulted in changes of management decision in 45% of the patients. fold higher risk for cardiac mortality and 5.5-fold
116
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content